-
Three types of viruses and 1 bacterium cause the vast majority of the new cases of cancer worldwide that are attributable to infections, according to a new study of global data.
11 May 2012 | Medscape (requires registration)
-
Aethlon Medical, Inc., the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, reported today that the presence of Hepatitis C virus (HCV) is currently undetectable in all infected patients that have been treated with the Aethlon Hemopurifier® in combination with peginterferon+ribavirin (PR) drug therapy and monitored for at least ninety days.
08 May 2012 | MarketWatch (press release)
-
Researchers in the U.S. have conducted a study of carefully selected HIV-positive people who were also co-infected with hepatitis C virus (HCV) and who needed a liver transplant. After the transplant and an average of three years of monitoring, researchers found that 60% of participants were still alive.
08 May 2012 | CATIE
-
The number of baby boomers dying from a "silent epidemic" of hepatitis C infections is increasing so rapidly that federal officials are planning a new nationwide push for widespread testing.
02 May 2012 | Los Angeles Times
-
The quality indicators focus on prevention, testing and assessment, treatment and support, and service organisation related to hepatitis C infection. We will establish a process for reporting on the quality indicators using data from existing national databases.
30 April 2012 | Health Care Improvement Scotland
-
U.S. drug regulators are changing the label for Merck & Co Inc's recently approved Victrelis treatment for hepatitis C to show it should not be taken with some widely used HIV medicines.
27 April 2012 | Reuters
-
Healthcare guidance body NICE has today (25 April) issued final guidance recommending boceprevir (Victrelis, Merck Sharp & Dohme) and telaprevir (Incivo, Janssen Cilag), in combination with peginterferon alfa and ribavirin, as options for the treatment of genotype 1 chronic hepatitis C in adults with compensated liver disease.
25 April 2012 | NICE press release
-
Those who have a positive family history of liver cancer are more likely to develop hepatocellular carcinomas (HCC), a new study has suggested. The study also showed 70-fold elevated risk of HCC in those with liver cancer in the family and markers for hepatitis B (HBV) or hepatitis C (HCV).
25 April 2012 | Times of India
-
The antiviral agent telaprevir (Incivek) has been associated with severe cutaneous eruptions, including the DRESS syndrome (drug reaction with eosinophilia and systemic symptoms), a new report warns.
24 April 2012 | Medscape (requires free registration)
-
Wow, it's been a busy few days at the European Association for the Study of the Liver (EASL) annual meeting in this beautiful Catalan capital. Investors obsessed with emerging hepatitis C therapies had plenty of new data to analyze.
23 April 2012 | The Street
Talking points: a checklist for you and your doctorTalking points is designed to help you talk to your doctor about HIV
treatment.
Preventing HIVAn essential resource providing evidence-based information on preventing HIV infection. 
Come and see us at the BHIVA conference!18 April 2012This morning, I boarded a train at Euston with one...
Community action on harm reduction (CAHR)16 April 2012We’ve been working on the design and
development of a new...
HIV treatment update – Spring 201212 April 2012The new edition of HIV
treatment update (HTU) is now available...